Listen on the go
CORRECT!
Next question
touchIMMUNOLOGY touchIMMUNOLOGY

Start Learning

Touch Loading image
JOURNALS
Start Learning
Breakthroughs in MASH: Highlights from EASL 2024
Luis Felipe Ensina, leading innovation in allergy and immunology
JOURNALS
Start Learning
Global Impact, Brazilian Roots: Prof. Ensina’s Journey Leading Innovation in Allergy and Immunology
CONFERENCE HUB
Start Learning
Efficacy of secukinumab as first-line bDMARD vs standard-of-care
touchMDT
Start Learning
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team
CE/CME ACCREDITED
JOURNALS
Start Learning
Breakthrough treatments for hereditary angioedema revealed at EAACI 2024
JOURNALS
Start Learning
A Career in Endoscopy: 5 insights from UEG Lifetime Achievement Awardee – Paul Fockens
touchPANEL DISCUSSION
Start Learning
Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management
CE/CME ACCREDITED
endoscopic procedure duodenum
JOURNALS
Start Learning
Novel strategy shows potential to reduce insulin dependence in type 2 diabetes
Bioinformatics immuno-oncology
JOURNALS
Start Learning
Shaping Immuno-oncology and Precision Medicine through Bioinformatics: Celebrating a pioneer in progress, Hassan Abushukair
www.touchimmunology.com
JOURNALS
Start Learning
New data support the efficacy and safety of cendakimab in eosinophilic oesophagitis

to view Favourites, Keep Notes and Track CME Credits

Favourites
Foreword – touchREVIEWS in RMD, Volume 4, Issue 1, 2025
View
Hypermobility Spectrum Disorders and Pain: A Review of Recent Developments and their Application to Clinical Practice 
View
Treating moderate-to-severe atopic dermatitis in children and adolescents: Insights from the experts
View
Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions
View
A Career in Endoscopy: 5 insights from UEG Lifetime Achievement Awardee – Paul Fockens
View
Increased infliximab clearance in patients hospitalized with severe ulcerative colitis may lead to underexposure
View
Breakthrough treatments for hereditary angioedema revealed at EAACI 2024
View
Honouring Prof. Marcus Maurer
View
Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management
View
Advances in the treatment of lupus and Sjögren’s disease
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup